Celadon Pharmaceuticals (LSE:CEL) Gross Margin % : 150.00% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Celadon Pharmaceuticals's Gross Profit for the six months ended in Dec. 2023 was €0.12 Mil. Celadon Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was €0.08 Mil. Therefore, Celadon Pharmaceuticals's Gross Margin % for the quarter that ended in Dec. 2023 was 150.00%.

The historical rank and industry rank for Celadon Pharmaceuticals's Gross Margin % or its related term are showing as below:

LSE:CEL' s Gross Margin % Range Over the Past 10 Years
Min: -600 Med: -435.72 Max: 100
Current: 100

During the past 5 years, the highest Gross Margin % of Celadon Pharmaceuticals was 100.00%. The lowest was -600.00%. And the median was -435.72%.

LSE:CEL's Gross Margin % is ranked better than
99.39% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.375 vs LSE:CEL: 100.00

Celadon Pharmaceuticals had a gross margin of 150.00% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Celadon Pharmaceuticals was 0.00% per year.

Celadon Pharmaceuticals Gross Margin % Historical Data

The historical data trend for Celadon Pharmaceuticals's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Gross Margin % Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

-600.00

-271.43

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Margin %	Get a 7-Day Free Trial			-600.00	-107.69	-413.33	-333.33	150.00

Competitive Comparison of Celadon Pharmaceuticals's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celadon Pharmaceuticals's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's Gross Margin % falls into.

Celadon Pharmaceuticals Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Celadon Pharmaceuticals's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	0.1	/	0.087
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.087 - 0)	/	0.087
	=	N/A %

Celadon Pharmaceuticals's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0.1	/	0.078
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.078 - -0.039)	/	0.078
	=	150.00 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Celadon Pharmaceuticals (LSE:CEL) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Celadon Pharmaceuticals had a gross margin of 150.00% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Celadon Pharmaceuticals Gross Margin % Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines